Search for: "KING PHARMACEUTICALS RESEARCH AND DEVELOPMENT, INC." Results 1 - 20 of 40
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Nov 2009, 9:28 pm
On Nov. 2, King Pharmaceuticals, Inc., Monarch Pharmaceuticals, Inc., King Pharmaceuticals Research and Development, Inc., and Gentrac, Inc., filed suit against Seattle-based ZymoGenetics, Inc., in the Eastern District of Tennessee. [read post]
7 Sep 2009, 9:34 pm
Sandoz Inc. 2:09-cv-04513; filed September 1, 2009 in the District Court of New Jersey • Plaintiffs: King Pharmaceuticals Inc.; King Pharmaceuticals Research and Development, Inc.; Elan Corporation, PLC.; Elan Pharma International Ltd. [read post]
12 Jan 2007, 6:20 pm
King Pharmaceuticals (Westlaw cite is 2006 WL 3716920), and the case number is WDQ-04-3521The blog had noted: the Court [in Merck v. [read post]
14 May 2010, 4:00 am by FDABlog HPM
District Court for the District of New Jersey (King Pharmaceuticals Inc., King Pharmaceuticals Research and Development Inc., Pharmaceutical IP Holding Inc. v. [read post]
10 Jun 2012, 1:09 pm by Schachtman
For example, women with herpes are more likely to develop cervical cancer than other women. [read post]
9 Sep 2009, 7:14 am
(America-Israel Patent Law) USPTO says some requests for patent term adjustment reconsideration are premature (Patent Docs) US: New York Times article ‘For Profit, Industry Seeks Cancer Drugs’ reports on cancer drug development (Patent Docs)   Products Angiomax (Bivalirudin) – US: Last-minute extension of pharmaceutical product life, or just throwing up a smokescreen? [read post]
19 Sep 2013, 12:35 pm
Cuevas conducted research projects for UHP senior management on Integrated Delivery Systems to help the organization develop strategic plans to adjust to the changing care delivery models and incentives system. [read post]
16 Nov 2007, 4:00 am
: (LawFont),BrazilBrazil pays the price for compulsory licensing: (IAM), (Generic Pharmaceuticals & IP), CanadaThe Chronicle reports that Honourable Mr. [read post]
8 Dec 2007, 11:00 am
: (IP Think Tank), WIPO - Idris gets paid out to leave early: (IAM), (Patent Prospector), Deutsche Grammophon ditches DRM: (ArsTechnica)PharmaFDA revisits NCE exclusivity for enantiomers: (Arnall Golden & Gregory), Accupril (Quinapril) - Judge finds against Teva and holds Warner-Lambert patent enabled: (IPLaw360), (OrangeBookBlog), Altace / Tritace / Ramace (Ramipril) - King Pharmaceuticals loses CAFC rehearing bid:… [read post]
27 Aug 2011, 7:55 pm
This is "the sport of kings," that only large corporations can play. [read post]
1 Dec 2007, 9:00 am
: (SpicyIP),SpicyIP Petition: Indian Patent Database: (SpicyIP), Natco (unsurprisingly) considering challenge to HC ruling on Glivec: (SpicyIP), Music copyright infringement in India: (SpicyIP), Indian centres drive US patent rush: (SpicyIP), When faces are not billboards: (SpicyIP), Educomp - an unusual approach to property development - supply IP Schools: (SpicyIP), Copyright notices to ISPs on the rise: (SpicyIP),IndonesiaIndonesia Mulls Compulsory Licences On Three More HIV/AIDS… [read post]
25 Jan 2010, 5:00 am by Beck, et al.
Pa. 1989); In re Bexar County Health Facility Development Corp. [read post]
15 Jan 2008, 3:06 am
Sorensen Research and Development Trust et al filed 05/11/07 1:07-cv-02758 Tuthill Corporation v. [read post]
13 Sep 2019, 6:00 am by Guest Blogger
And to the extent that the justices have internalized such second-order attitudes about the extent to which they should hold back on effectuating their first-order attitudes, these second-order attitudes may offer an alternative explanation for why the Court has often developed doctrines that restrain even the first-order attitudes of those who have developed and internalized them. [read post]
9 Apr 2015, 11:59 am by Lawrence B. Ebert
Chien, Of Trolls, Davids, Goliaths, and Kings: Narratives and Evidence in the Litigation of High-Tech Patents, 87 N.C. [read post]
17 Aug 2009, 10:44 am
(Winchester, MA; Lily Yamamoto, President) Almaz Development, Inc. [read post]
4 May 2011, 7:52 am by Tron Emptage
Barry Lipton, Chris Laws and Linda Li, “Narcotics in Workers Compensation,” NCCI Research Brief, December 2009 p.5. 8. [read post]
9 Nov 2015, 7:09 am
  In fact, product liability law often follows a “needs of the many” approach that supports research, development, and limitation of liability for prescription medical products, where large damage awards can occur in the Wink of an Eye and can result in The Doomsday Machine for such products. [read post]